Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
A Pharmacokinetic Dose Proportionality Study of Canagliflozin in Healthy Volunteers
This study has been completed.
Study NCT01340677 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received on April 21, 2011. Last Updated on August 16, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Interventions listed in this trial
Canagliflozin, 50 mg
Canagliflozin, 300 mg
Canagliflozin, 100 mg
Sponsors listed in this trial
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers